Searched over 200M research papers
10 papers analyzed
These studies suggest that type 2 diabetes is a multifactorial disease influenced by genetic and environmental factors, characterized by improper insulin use and production, and managed through a combination of lifestyle changes and multiple drug treatments.
19 papers analyzed
Type 2 diabetes (T2D) is a complex and heterogeneous disorder influenced by both genetic and environmental factors. One theory suggests that T2D may result from the evolution of a "thrifty genotype" that was advantageous in past environments but is detrimental today. Another theory posits that T2D could be an adult metabolic response to fetal malnutrition. Genetic predispositions combined with lifestyle factors such as obesity, unhealthy diet, and physical inactivity significantly contribute to the development of T2D .
The primary issues in T2D are insulin resistance and defective insulin secretion by pancreatic beta-cells. Insulin resistance, often caused by central obesity, leads to a cluster of metabolic abnormalities including glucose intolerance, hypertension, and dyslipidemia . Beta-cell dysfunction results in inadequate insulin production, exacerbating hyperglycemia . These defects are central to the pathophysiology of T2D and are influenced by both genetic and environmental factors .
Individuals with T2D are at high risk for both microvascular complications (such as retinopathy, nephropathy, and neuropathy) and macrovascular complications (including cardiovascular diseases) . These complications arise due to chronic hyperglycemia and the metabolic syndrome associated with insulin resistance . Effective management of T2D involves controlling blood glucose levels, blood pressure, and lipid profiles to reduce the risk of these complications.
T2D is increasingly recognized as a highly heterogeneous disease with varying clinical characteristics, disease progression, and response to treatment among individuals . Recent research has identified distinct subtypes of T2D based on clinical parameters such as age at onset, body mass index (BMI), and measures of insulin resistance and secretion. These subtypes have different risks for complications and comorbidities, highlighting the need for personalized treatment approaches.
T2D is a growing global health problem, affecting over 150 million people worldwide and accounting for more than 90% of diabetes cases . The prevalence of T2D continues to rise, driven by increasing rates of obesity and sedentary lifestyles. This epidemic places a significant burden on healthcare systems and underscores the importance of early detection and effective management to prevent complications.
Management of T2D involves a combination of lifestyle modifications and pharmacological treatments. Oral antihyperglycemic agents work by increasing insulin secretion, decreasing insulin resistance, or delaying carbohydrate absorption. Long-term glycemic control often requires a progressive, stepwise approach, including combination therapy with oral agents and insulin. Novel medications are being developed to enhance insulin sensitivity and prevent beta-cell failure, aiming to improve patient outcomes and quality of life.
Type 2 diabetes is a multifaceted disease with complex interactions between genetic and environmental factors. Understanding its heterogeneity and the underlying pathophysiological mechanisms is crucial for developing personalized treatment strategies. Effective management and early intervention can significantly reduce the risk of complications, improving the quality of life for individuals with T2D.
Most relevant research papers on this topic